Home
About
FAQ
History (4)
Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.
Echocardiographic predictors of atrial fibrillation in patients with heart failure with preserved ejection fraction.
Exercise physiology in heart failure and preserved ejection fraction.
Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Exercise physiology in heart failure and preserved ejection fraction.
Haykowsky MJ, Kitzman DW. Exercise physiology in heart failure and preserved ejection fraction. Heart Fail Clin. 2014 Jul; 10(3):445-52.
View in:
PubMed
subject areas
Aged
Exercise
Exercise Test
Exercise Tolerance
Female
Heart Failure
Humans
Male
Middle Aged
Muscle, Skeletal
Oxygen Consumption
Randomized Controlled Trials as Topic
Reference Values
Sensitivity and Specificity
Stroke Volume
Syndrome
Ventricular Function, Left
authors with profiles
Dalane W. Kitzman MD